Tivozanib hydrate | MedChemExpress (MCE)
Tivozanib hydrate (AV-951 hydrate; KRN951 hydrate) is the hydrate form of Tivozanib (HY-10977). Tivozanib hydrate is a selective, orally active inhibitor for vascular endothelial growth factor receptor (VEGFR)-1, 2 3, with IC50s of 30, 6.5 and 15 nM, respectively. Tivozanib hydrate exhibits antitumor efficacy[1].
| Trivial name | Tivozanib hydrate |
| Catalog Number | HY-112467 |
| Alternative Name(s) | AV-951 hydrate; KRN951 hydrate |
| Research Area | Cancer |
| CAS# | 682745-40-0 |
| Purity | ≥98.0% |
| SMILES | O=C(NC1=CC=C(C=C1Cl)OC2=CC=NC3=CC(OC)=C(C=C23)OC)NC4=NOC(C)=C4.O |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/tivozanib-hydrate.html |